Cargando…
Emerging roles of mesenchymal stem cell therapy in patients with critical limb ischemia
Critical limb ischemia (CLI), the terminal stage of peripheral arterial disease (PAD), is characterized by an extremely high risk of amputation and vascular issues, resulting in severe morbidity and mortality. In patients with severe limb ischemia with no alternative therapy options, such as endovas...
Autores principales: | Shirbaghaee, Zeinab, Hassani, Mohammad, Heidari Keshel, Saeed, Soleimani, Masoud |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449296/ https://www.ncbi.nlm.nih.gov/pubmed/36068595 http://dx.doi.org/10.1186/s13287-022-03148-9 |
Ejemplares similares
-
Report of a phase 1 clinical trial for safety assessment of human placental mesenchymal stem cells therapy in patients with critical limb ischemia (CLI)
por: Shirbaghaee, Zeinab, et al.
Publicado: (2023) -
Therapeutic role of mesenchymal stem cell-derived exosomes in respiratory disease
por: Zargar, Mehdi Jahedi, et al.
Publicado: (2022) -
Safety of Intraparenchymal Injection of Allogenic Placenta Mesenchymal Stem Cells Derived Exosome in Patients Undergoing Decompressive Craniectomy Following Malignant Middle Cerebral Artery Infarct, A Pilot Randomized Clinical Trial
por: Dehghani, Leila, et al.
Publicado: (2022) -
The Emerging Role of Mesenchymal Stem Cells in Tissue Engineering
por: Dehghanifard, Ali, et al.
Publicado: (2013) -
Stem Cell Therapy in Critical Limb Ischemia
por: Jeyaraman, Madhan, et al.
Publicado: (2023)